Vanguard Capital Management reports 5.23% stake in Merit Medical (MMSI)

Rhea-AI Filing Summary

Merit Medical Systems Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 3,109,720 shares of Common Stock, representing 5.23% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over all 3,109,720 shares and sole voting power over 453,557 shares. The disclosure notes holdings include shares held for Vanguard funds and managed accounts and names related Vanguard affiliates.

Insights

Institutional Ownership Analyst

Vanguard holds a modest >5% stake in Merit Medical as of 03/31/2026.

Vanguard Capital Management reports beneficial ownership of 3,109,720 shares (5.23%). The filing attributes sole dispositive power for those shares to Vanguard Capital Management and sole voting power for 453,557 shares.

Institutional filings at the 5% threshold often appear in routine ownership monitoring; subsequent disclosures or fund-level schedules may show trading activity. Timing here is tied to the 03/31/2026 reporting date with the form signed on 04/30/2026.

Corporate Governance Specialist

Disclosure clarifies voting and dispositive roles across Vanguard affiliates.

The statement explains that the reported position includes securities held by Vanguard funds and sleeves where Vanguard exercises dispositive power and identifies several affiliated entities by name. The text follows SEC Release No. 34-39538 guidance on aggregated reporting.

Investors seeking more detail should consult fund-level reports or periodic 13F/13D filings for trade-level changes; this Schedule 13G is a snapshot of beneficial ownership as reported.

Key Figures

Reporting date: 03/31/2026 Beneficial ownership: 3,109,720 shares Percent of class: 5.23% +3 more

6 metrics

Reporting date 03/31/2026 Beneficial-ownership snapshot date

Beneficial ownership 3,109,720 shares Amount beneficially owned reported by Vanguard Capital Management

Percent of class 5.23% Percentage of common stock class beneficially owned

Sole voting power 453,557 shares Shares for which Vanguard reports sole power to vote

Sole dispositive power 3,109,720 shares Shares for which Vanguard reports sole power to dispose

Form signed 04/30/2026 Signature date on the Schedule 13G

Key Terms

Schedule 13G, beneficial ownership, dispositive power, SEC Release No. 34-39538

4 terms

Schedule 13G regulatory

"Schedule 13G: Vanguard Capital Management reports beneficial ownership"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficial ownership financial

"Amount beneficially owned: 3109720 (b) Percent of class: 5.23 %"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 3109720"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

SEC Release No. 34-39538 regulatory

"In accordance with SEC Release No. 34-39538 (January 12, 1998)"

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Merit Medical Systems Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

589889104

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 589889104

1

Names of Reporting Persons

Vanguard Capital Management

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 453,557.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,109,720.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,109,720.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.23 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Merit Medical Systems Inc
(b)	Address of issuer's principal executive offices: 1600 West Merit Parkway, South Jordan, UT, 84095
Item 2.
(a)	Name of person filing: Vanguard Capital Management
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 589889104
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3109720
(b)	Percent of class: 5.23 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 453557
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3109720
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vanguard Capital Management

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	04/30/2026

FAQ

What stake does Vanguard Capital Management report in MMSI?

Vanguard reports beneficial ownership of 3,109,720 shares, equal to 5.23% of the class as of 03/31/2026. The filing indicates sole dispositive power over the full amount and sole voting power over 453,557 shares.

Does the Schedule 13G show who controls the votes for MMSI shares?

Yes. Vanguard reports sole voting power for 453,557 shares and sole dispositive power for 3,109,720 shares. The filing clarifies multiple Vanguard affiliates are involved in managed holdings.

What date is the ownership figure reported for MMSI?

The ownership is reported as of 03/31/2026 and the Schedule 13G was signed on 04/30/2026. Those dates anchor the snapshot of beneficial ownership disclosed in the form.

Are the reported MMSI shares held for funds or clients?

The filing states the position includes securities held by Vanguard funds and managed accounts over which affiliates exercise dispositive power. It lists specific Vanguard affiliates as part of the aggregation.

Does Vanguard identify any other person with >5% interest in MMSI?

No. The Schedule 13G states no other person known to Vanguard has the right to dividends or proceeds exceeding 5% of the class in the reported holdings.